These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 19307243)

  • 21. Assisted circulation using the TandemHeart during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG.
    Vranckx P; Schultz CJ; Valgimigli M; Eindhoven JA; Kappetein AP; Regar ES; Van Domburg R; Serruys PW
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):302-10. PubMed ID: 19360865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative economic analyses of minimally invasive direct coronary artery bypass surgery.
    Gray DT; Veenstra DL
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):618-24. PubMed ID: 12658204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meditations on secondary revascularisation in the aftermath of the SYNTAX trial.
    Garg S; Serruys PW
    EuroIntervention; 2009 May; 5 Suppl D():D14-20. PubMed ID: 19736064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of 5-year outcomes of CABG vs PCI with stenting in patients with multivessel disease.
    Athappan G; Vinodhkumaradithyaa A; Srinivasan M; Jeyaseelan L; Ponniah T
    Minerva Cardioangiol; 2008 Oct; 56(5):453-60. PubMed ID: 18813180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angioplasty versus coronary artery by-pass surgery: a reappraisal.
    Chakraborty R
    J Indian Med Assoc; 1999 Jul; 97(7):271-5. PubMed ID: 10643190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revascularization in high risk patients: diabetes mellitus.
    Cola C; Sabaté M
    Minerva Cardioangiol; 2007 Oct; 55(5):557-77. PubMed ID: 17912163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
    Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of diabetes on five-year outcomes of patients with multivessel coronary artery disease.
    Hueb W; Gersh BJ; Costa F; Lopes N; Soares PR; Dutra P; Jatene F; Pereira AC; Góis AF; Oliveira SA; Ramires JA
    Ann Thorac Surg; 2007 Jan; 83(1):93-9. PubMed ID: 17184637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial.
    Farkouh ME; Dangas G; Leon MB; Smith C; Nesto R; Buse JB; Cohen DJ; Mahoney E; Sleeper L; King S; Domanski M; McKinlay S; Fuster V
    Am Heart J; 2008 Feb; 155(2):215-23. PubMed ID: 18215589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Stenting or coronary artery bypass surgery for triple vessel disease?].
    Sleilaty G; Achouh P; Fabiani JN
    Ann Cardiol Angeiol (Paris); 2009 Apr; 58(2):104-12. PubMed ID: 18930176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary artery bypass grafting (CABG): reassessing efficacy, safety, and cost.
    Cundiff DK
    MedGenMed; 2002 Jun; 4(2):7. PubMed ID: 12145567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CABG or PCI: which is better? Bypass or angioplasty with stent? For multivessel disease, some say surgery is the superior treatment.
    Health News; 2006 May; 12(5):8-10. PubMed ID: 16685751
    [No Abstract]   [Full Text] [Related]  

  • 33. The SYNTAX score in practice: an aid for patient selection for complex PCI.
    Feldman T
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):618-9. PubMed ID: 19309708
    [No Abstract]   [Full Text] [Related]  

  • 34. Preoperative coronary revascularization in high-risk patients undergoing vascular surgery: a core review.
    Kertai MD
    Anesth Analg; 2008 Mar; 106(3):751-8. PubMed ID: 18292413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of coronary artery disease: coronary by-pass or balloon dilatation?].
    Heikkilä J; Järvinen A
    Duodecim; 2000; 116(19):2087-96. PubMed ID: 12017729
    [No Abstract]   [Full Text] [Related]  

  • 36. Does prior PCI influence the clinical outcome of CABG?
    Taggart DP
    EuroIntervention; 2009 May; 5 Suppl D():D21-4. PubMed ID: 19736065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Choosing between percutaneous coronary intervention and coronary artery bypass grafting for patients with multivessel disease: what can we learn from the Arterial Revascularization Therapy Study (ARTS)?
    Berger PB; Sketch MH; Califf RM
    Circulation; 2004 Mar; 109(9):1079-81. PubMed ID: 15007018
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of drug-eluting stents in venous coronary artery bypass grafts.
    Hernandez-Antolín R; Alfonso F; Jimenez P
    EuroIntervention; 2009 May; 5 Suppl D():D51-7. PubMed ID: 19736072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationale for the revascularization arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
    Barsness GW; Gersh BJ; Brooks MM; Frye RL;
    Am J Cardiol; 2006 Jun; 97(12A):31G-40G. PubMed ID: 16813736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-eluting stents or drug-eluting conduits for multivessel disease?
    Alfieri O; Maisano F; Benussi S; Toracca L; Castiglioni A
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):359-61. PubMed ID: 17443103
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.